Wanbangde Pharmaceutical Holding Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 385.23 million compared to CNY 332.63 million a year ago. Revenue was CNY 385.23 million compared to CNY 332.63 million a year ago.

Net income was CNY 27.34 million compared to CNY 24.79 million a year ago. Basic earnings per share from continuing operations was CNY 0.0442 compared to CNY 0.04 a year ago. Diluted earnings per share from continuing operations was CNY 0.0442 compared to CNY 0.04 a year ago.